OrphanDrug
OrphanDrug
Pharma Knowledge Base

hydrocephalus-obesity-hypogonadism syndrome

ORPHA: 2183

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

This syndrome is characterized by the association of congenital hydrocephalus, centripetal obesity, hypogonadism, intellectual deficit and short stature

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with hydrocephalus-obesity-hypogonadism syndrome, sourced from HPO and Orphanet clinical annotations.

HydrocephalusShort neckGynecomastiaHypergonadotropic hypogonadismMild intellectual disabilityObesityMitral valve prolapseLow posterior hairlineHigh, narrow palateCubitus valgusShort statureShort 4th metacarpalAzoospermiaAbnormality of the hypothalamus-pituitary axisAbsent facial hairSparse facial hair

Classification & Codes

Orphanet Code

ORPHA:2183
hydrocephalus-obesity-hypogonadism syndrome
OrphanetORPHA:2183
Treatments0 drug(s)
Symptoms on record16 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO